Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
61 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
62 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
63 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
64 Fine‑needle aspiration cytology versus core needle lymph node biopsy in axillary staging of breast cancer Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
65 Lectin-Like OLR1 3′ UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes Department of Anesthesia, Intensive care and Pain management Dr. Mohamed Ahmed Mohamed Mostafa 2022
66 T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections Department of Clinical Pathology Dr. Abeer Mostafa Mostafa Darwish 2022
67 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
68 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2022
69 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
70 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2022